BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12447866)

  • 1. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
    Chu CJ; Hussain M; Lok AS
    Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM; Chen YC; Tai DI; Liaw YF
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M; Zhou X; Wei L; Qiu S; Zhou T; Li L; Gu X; Luo M; Zheng X
    Virol J; 2007 Sep; 4():93. PubMed ID: 17892580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH; Yu SK; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Lee CH; Byun KS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1220-5. PubMed ID: 17532786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.